{"prompt": "['GALDERMA R&D', 'RD.06.SPR.118295 Protocol V02 04Jun2019', 'Page 37 of 88', 'Treatment compliance will be assessed using the subject daily diary.', 'CCI', 'CCI', '6.4', 'Dose modification', 'Subjects are encouraged to use from the Baseline visit and throughout the study the provided', 'moisturizer,', 'CCI', 'Signs and symptoms of local cutaneous irritation assessed with a local tolerability scale will be', 'considered as Adverse Events', 'CCI', '7', 'CLINICAL TRIAL ASSESSMENT', '7.1', 'Efficacy assessments', 'IGA and PGA assessments are to be performed by a qualified evaluator.', 'CCI', 'CCI', '7.1.1', 'Efficacy measurements', 'IGA/PGA and Lesion Counts will be performed for face and trunk separately. CCI', 'Refer to Appendix 13.8.']['GALDERMA R&D', 'RD.06.SPR.118295 Protocol V02 04Jun2019', 'Page 38 of 88', 'CCI', '7.1.1.1', \"IGA (Investigator's global assessment) of facial acne\", 'The areas defined for IGA assessment are forehead, each cheek, chin, and nose. IGA will be', 'confined to a global assessment of each area defined above.', 'CCI', 'The IGA will be assessed', 'according to the following scale:', \"Investigator's Global Assessment Scale (IGA) Face\", '0', 'Clear', 'Clear skin with no inflammatory or non-inflammatory lesions.', '1', 'Almost Clear', 'A few scattered comedones and a few small papules.', '2', 'Mild', 'Easily recognizable; less than half the surface is involved. Some comedones and some', 'papules and pustules.', '3', 'Moderate', 'More than half of the surface is involved. Many comedones, papules and pustules. One', 'nodule may be present.', '4', 'Severe', 'Entire surface is involved. Covered with comedones, numerous papules and pustules.', 'Few nodules may be present.', '7.1.1.2', 'PGA (Physician Global Assessment) of truncal acne', 'The areas defined for PGA assessment are shoulders, upper back, and upper anterior chest which', 'are accessible to self-application by the subject, i.e., the regions that the subject can easily reach', 'and apply the study drug without assistance.', 'PGA will be confined to a global assessment of each areas defined above. The PGA is a snapshot', 'static assessment to be done prior to detailed lesion counts.', 'CCI']['GALDERMA R&D', 'RD.06.SPR.118295 Protocol V02 04Jun2019', 'Page 39 of 88', 'The PGA is outlined in the following table', 'CC', 'Physician Global Assessment Scale (PGA) Trunk', '0', 'Clear', 'Clear skin with no inflammatory or non-inflammatory lesions.', '1', 'Almost Clear', 'A few scattered comedones and a few small papules.', '2', 'Mild', 'Easily recognizable; less than half the surface is involved. Some comedones and some', 'papules and pustules.', '3', 'Moderate', 'More than half of the surface is involved. Many comedones, papules and pustules. One', 'nodule may be present.', '4', 'Severe', 'Entire surface is involved. Covered with comedones, numerous papules and pustules.', 'Few nodules may be present.']\n\n###\n\n", "completion": "END"}